Clinical Trial Update: A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Pfizer completed a Phase 1 dose-finding study to determine the best dose of SU011248 when given with pemetrexed, with or without cisplatin or carboplatin, in pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Pemetrexed (pemetrexed)
• SU011248

Snippet

Sponsor: Pfizer | Conditions: Neoplasms | Phase 1 | Status: COMPLETED